Skip to main content
Premium Trial:

Request an Annual Quote

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Oct 7, 2004

 

BioCommerce Week’s Index to the Diversified Molecular Biology Tools Companies

On a week when Merck withdrew its anti-inflammatory medicine Vioxx from the market, the BioCommerce Week Index of Diversified Molecular Biology Tools Companies recovered from last week’s 3-percent fall, registering a 2-percent gain for the weekly period ending Tuesday.

This index of 15 companies has recorded gains in three out of the four weeks since it was introduced.

While the Amex Pharmaceutical Index was down 1 percent for the week, the Amex biotechnology index recorded a 2-percent gain for the five-day period. The Dow Jones Industrial Average was up about 1 percent for the week, the S&P 500 improved better than 2 percent, while the Nasdaq composite index finished above 4 percent for the week.

Agilent, last week’s loser with an 8 percent drop, led 14 BCW Index gainers with a 9-percent improvement, closing at $23.21 Tuesday, compared to a $21.29 close last week. Applied Biosystems and Stratagene each recorded 5 percent gains, while Molecular Devices, Thermo Electron, PerkinElmer, and Bio-Rad each had 4-percent gains.

Bruker was the only company falling, dropping to $3.31 from last week’s close of $3.52.

Following is a list of when the BCW Index companies will report their financials for the quarter ended Sept. 30:

  • Agilent, Q4 2004: Nov. 11, 2004
  • Applied Biosystems, Q1 2005: Oct. 25, 2004
  • Becton Dickinson, Q4 2004: Nov. 4, 2004
  • Beckman Coulter, Q3 2004: Nov. 4, 2004
  • Bio-Rad, Q3 2004: Nov. 1, 2004
  • Bruker, Q3 2004: Nov. 1, 2004
  • General Electric, Q3 2004: Oct. 8, 2004
  • Harvard Biosciences, Q3 2004: Oct. 25, 2004
  • Invitrogen, Q3 2004: Oct. 25, 2004
  • Molecular Devices, Q3 2004: no date set
  • PerkinElmer, Q3 2004: Oct. 18, 2004,
  • Sigma-Aldrich, Q3 2004: Oct. 21, 2004
  • Stratagene, Q3 2004: Nov. 8, 2004
  • Thermo, Q2 2004: no date set
  • Waters, Q3 2004: Oct. 25, 2004
File Attachments